Your browser doesn't support javascript.
loading
Mitohormesis in Hypothalamic POMC Neurons Mediates Regular Exercise-Induced High-Turnover Metabolism.
Kang, Gil Myoung; Min, Se Hee; Lee, Chan Hee; Kim, Ji Ye; Lim, Hyo Sun; Choi, Min Jeong; Jung, Saet-Byel; Park, Jae Woo; Kim, Seongjun; Park, Chae Beom; Dugu, Hong; Choi, Jong Han; Jang, Won Hee; Park, Se Eun; Cho, Young Min; Kim, Jae Geun; Kim, Kyung-Gon; Choi, Cheol Soo; Kim, Young-Bum; Lee, Changhan; Shong, Minho; Kim, Min-Seon.
Afiliação
  • Kang GM; Asan Institute for Life Science, University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Min SH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Diabetes Center, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Lee CH; Asan Institute for Life Science, University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Kim JY; Asan Institute for Life Science, University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Lim HS; Department of Biomedical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Choi MJ; Research Center for Endocrine and Metabolic Diseases, Department of Medical Science, School of Medicine, Chungnam National University, Daejeon 35015, Korea.
  • Jung SB; Research Center for Endocrine and Metabolic Diseases, Department of Medical Science, School of Medicine, Chungnam National University, Daejeon 35015, Korea.
  • Park JW; Department of Biomedical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Kim S; Department of Biomedical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Park CB; Department of Biomedical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Dugu H; Department of Biomedical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Choi JH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Diabetes Center, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Jang WH; Department of Biomedical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Park SE; Department of Biomedical Science, Asan Medical Institute of Convergence Science and Technology, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Cho YM; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Kim JG; Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22012, Korea.
  • Kim KG; Asan Institute for Life Science, University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Choi CS; Lee Gil Ya Cancer and Diabetes Institute, Korea Mouse Metabolic Phenotyping Center, Gachon University, Inchon 21999, Korea.
  • Kim YB; Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.
  • Lee C; Leonard Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA. Electronic address: changhan.lee@usc.edu.
  • Shong M; Research Center for Endocrine and Metabolic Diseases, Department of Medical Science, School of Medicine, Chungnam National University, Daejeon 35015, Korea; Department of Internal Medicine, Chungnam National University Hospital, Daejeon 35015, Korea. Electronic address: minhoshong@gmail.com.
  • Kim MS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Diabetes Center, Asan Medical Center and University of Ulsan College of Medicine, Seoul 05505, Korea. Electronic address: mskim@amc.seoul.kr.
Cell Metab ; 33(2): 334-349.e6, 2021 02 02.
Article em En | MEDLINE | ID: mdl-33535098
ABSTRACT
Low-grade mitochondrial stress can promote health and longevity, a phenomenon termed mitohormesis. Here, we demonstrate the opposing metabolic effects of low-level and high-level mitochondrial ribosomal (mitoribosomal) stress in hypothalamic proopiomelanocortin (POMC) neurons. POMC neuron-specific severe mitoribosomal stress due to Crif1 homodeficiency causes obesity in mice. By contrast, mild mitoribosomal stress caused by Crif1 heterodeficiency in POMC neurons leads to high-turnover metabolism and resistance to obesity. These metabolic benefits are mediated by enhanced thermogenesis and mitochondrial unfolded protein responses (UPRmt) in distal adipose tissues. In POMC neurons, partial Crif1 deficiency increases the expression of ß-endorphin (ß-END) and mitochondrial DNA-encoded peptide MOTS-c. Central administration of MOTS-c or ß-END recapitulates the adipose phenotype of Crif1 heterodeficient mice, suggesting these factors as potential mediators. Consistently, regular running exercise at moderate intensity stimulates hypothalamic MOTS-c/ß-END expression and induces adipose tissue UPRmt and thermogenesis. Our findings indicate that POMC neuronal mitohormesis may underlie exercise-induced high-turnover metabolism.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Condicionamento Físico Animal / Pró-Opiomelanocortina / Hipotálamo / Mitocôndrias / Neurônios Idioma: En Revista: Cell Metab Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Condicionamento Físico Animal / Pró-Opiomelanocortina / Hipotálamo / Mitocôndrias / Neurônios Idioma: En Revista: Cell Metab Ano de publicação: 2021 Tipo de documento: Article